GlassScriptPhysician profile
Manesh Parikshak
NPI 1356438626
$61,157.36
in general payments reported to CMS, 2019-2025
30 companies · $15K in 2025
The $15K reported for 2025 was more than what 92% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $8,278 · 2021: $5,813 · 2022: $2,746 · 2023: $1,563 · 2024: $2,748 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,500 · Food and Beverage: $4,103 · Consulting Fee: $3,210 · Travel and Lodging: $3,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,500.00 |
| Food and Beverage | $4,103.11 |
| Consulting Fee | $3,210.00 |
| Travel and Lodging | $3,020.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47,319.10 | 2019-2025 | Lifevest |
| Angiodynamics, INC. | $4,512.09 | 2019-2025 | Angiovac, Alphavac |
| Edwards Lifesciences Corporation | $2,203.51 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Clearflow INC. | $1,701.75 | 2019-2021 | |
| Atricure, INC. | $1,391.93 | 2019-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Abiomed | $831.31 | 2019-2025 | Impella |
| Medtronic, INC. | $595.42 | 2021-2025 | Retia Medical |
| Zimmer Biomet Holdings, INC. | $413.58 | 2019-2022 | |
| Medtronic Vascular, INC. | $348.17 | 2019-2020 | |
| Ethicon US, LLC | $281.99 | 2023-2025 | Vistaseal, Echelon; Endopath |
| Lemaitre Vascular, INC. | $268.58 | 2021-2025 | Artegraft Vascular Graft, Restoreflow, Syntel Embolectomy Catheter (Spring Tip) |
| Smith+Nephew, INC. | $164.51 | 2019 | |
| La Jolla Pharmaceutical Company | $132.10 | 2025 | Giapreza |
| Intuitive Surgical, INC. | $98.81 | 2019 | |
| Saphena Medical, INC. | $98.34 | 2023 | Venapax |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $95.59 | 2019-2020 | |
| Corcym INC | $92.93 | 2025 | Perceval |
| Kci USA, INC. | $84.49 | 2019 | |
| Biomerieux INC | $81.90 | 2024-2025 | |
| Sanara Medtech INC. | $77.40 | 2021-2022 | |
| Abbott Laboratories | $50.92 | 2023-2025 | Perclose Prostyle, Epic |
| Boston Scientific Corporation | $50.91 | 2024-2025 | Enroute Transcarotid Neuroprotection System, Ranger |
| Kestra Medical Technology Services, INC. | $48.78 | 2024 | Assure Wcd |
| Vertex Pharmaceuticals Incorporated | $47.87 | 2025 | |
| Covidien LP | $42.20 | 2019 | |
| W. L. Gore & Associates, INC. | $33.51 | 2022-2024 | Gore Excluder Iliac Branch Endoprosthesis |
| Inari Medical, INC. | $25.02 | 2022 | |
| Getinge USA Sales, LLC | $24.69 | 2020 | |
| Vital Connect, INC | $24.39 | 2024 | Vitalpatch Rtm |
| Kls-Martin L.P. | $15.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manesh Parikshak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.